Visual and refractive outcomes of eyes with low corneal astigmatism implanted with low toric or non-toric trifocal intraocular lenses Authors: Robert Edward T Ang, Vincent P Bernal, Jan Philippe H Tan, Michelle Marie Q Araneta, Ma Melizza Theresa T Ramirez, Jocelyn Therese M Remo, Emerson M Cruz Published: 2026 ABSTRACT AbstractObjectiveTo evaluate visual and refractive outcomes of cataract patients with low corneal astigmatism (-0.50 D to -1.50 D) implanted with either a low toric or non-toric trifocal IOL.MethodsThis retrospective cross sectional study included patients with low corneal astigmatism measured by the IOLMaster 700 (Carl Zeiss AG, Germany). Patients received either a trifocal toric IOL (FineVision Toric POD FT) or a trifocal non-toric IOL (FineVision POD F or POD F GF). Toric implantations formed the TT (True Toric) group while non-toric IOLs were named as NTT (Non-Toric IOL, Toric) and those not recommended toric IOL placed in the NTNT group (Non-Toric IOL, Non-Toric). Visual acuity, refraction, and astigmatism were assessed preoperatively and 6–12 months postoperatively.ResultsAmong 167 eyes (88 TT, 65 NTT, 14 NTNT), postoperative uncorrected visual acuities were similar across groups. The TT IOLs are significantly more effective at reducing residual refractive cylinder, particularly in patients with preoperative astigmatism between − 0.50 D and − 1.50 D. While uncorrected distance, intermediate, and near visual acuities were generally comparable (non-inferior), the TT group achieved superior distance vision (UDVA) in the − 0.76 D to -1.00 D against-the-rule subgroup. Ultimately, low toric trifocal IOLs provide more predictable refractive outcomes and better astigmatism correction without increasing patient-reported visual disturbances like glare or haloes.ConclusionThe use of the low toric models of trifocal IOLs resulted in a significant reduction in preoperative corneal astigmatism, leading to good visual outcomes. Patients with − 0.50 D to -1.50 D of astigmatism benefit from these lenses, with correction being particularly effective for those with at least − 0.75 D of against-the-rule astigmatism.Keywords: Low corneal astigmatism, Trifocal toric intraocular lenses, Trifocal non-toric intraocular lenses, FineVision POD FT, FineVision POD F GF, FineVision POD F Introduction Cataracts are the leading cause of correctable blindness and visual impairment worldwide at 51% [1]. Modern cataract surgery is performed through phacoemulsification, which entails entering the eye through small incisions, breaking up the cataract into smaller pieces, and extracting the residual material through a vacuum-enclosed system. An artificial intraocular lens (IOL) is then inserted into the natural capsular bag as a replacement to restore good vision [2]. The cataract obstructs vision, and its removal will allow more light to enter the eye. At the same time, the IOL that replaces it can correct refractive errors and reduce dependence on glasses [3]. Refractive errors include spherical error (myopia/nearsightedness or hyperopia/farsightedness) and astigmatism. Astigmatism is the difference in meridional power of the eye due to the asymmetry of the curvature of the cornea and/or lens. Over 40% of adults in a pooled population have astigmatism, which has been deemed the most common refractive error worldwide according to Hashemi et al. in their recent systematic review and meta-analysis [4]. Visual acuity, contrast sensitivity, and overall visual quality of life are affected at all levels of light by astigmatism [5]. The exact cause of astigmatism is unknown, although multiple factors are known to influence the refractive error such as corneal irregularities, extraocular muscle tension, and cataracts [6]. In those patients who present for cataract surgery, 60% exhibit corneal astigmatism from − 0.75 D to -1.50 D [3]. Therefore, correction of corneal astigmatism is important for a significant number of patients [7]. In the Asian population, the overall prevalence of astigmatism was reported at 40 to 60.1% [8]. Correction of low degrees of astigmatism may potentially result in improved refractive outcomes [9]. Part of preoperative planning for cataract surgery includes ocular biometry to obtain measurements in determining the type and power of the IOL. The implanted IOL can be non-toric, which corrects the spherical error of the eye only (myopia or hyperopia), or a toric IOL version, which not only corrects spherical error but also the pre-existing corneal astigmatism [3]. Apart from categorizing IOLs as either toric or non-toric, the capability for presbyopia correction is another level of categorization of IOLs. Presbyopia is a condition wherein small print or objects nearer the eyes seem blurry without reading glasses [10]. If emmetropia or absence of refractive error for distance is desired, monofocal IOLs provide good far vision without spectacle use, but patients would still require spectacle correction for reading. Trifocal IOLs achieve good distance, intermediate, and near vision with minimal dependence on glasses for these distances [11]. To maximize the visual potential that IOLs can provide, it is therefore crucial to exert all efforts to target the least amount of all types of refractive error after surgery, astigmatism included [12]. Cataract screening involves obtaining keratometry, axial length, and anterior chamber depth measurements for IOL power calculation and selection of IOLs. Keratometry values showing pre-existing corneal astigmatism in excess of -1.50 D is considered significant and warrant the use of toric IOLs to neutralize the corneal astigmatism. However, there is no consensus on using toric IOLs for lower degrees of pre-existing corneal astigmatism. Several reasons include the limited availability of IOLs with low toric correction in different countries, the surgeon belief that these low levels are insignificant, the availability of other modalities of correcting astigmatism such as corneal incisions, the unpredictability of inducing astigmatism during surgery, and variations in postoperative wound healing. Residual astigmatism may hinder the achievement of the best possible visual acuity. It has been shown that correction of astigmatic errors ranging from − 0.50 D and up to -2.00 D during cataract surgery results in improvement of uncorrected visual acuity, leading to more satisfied spectacle-free individuals [1, 9, 13–16]. In a recent multivariate analysis by Schallhorn et al., they found that low levels of residual astigmatism in a large population of pseudophakic patients cause degradation of visual acuity and decreased patient satisfaction when implanted with either monofocal or trifocal IOLs. They recommended that corneal astigmatism greater than − 0.50 D should be included in surgical planning [13]. Trifocal IOLs are designed to provide good distance, intermediate, and near vision, but this is contingent on having the least amount of all types of refractive error. In a study by Ang et al. on induced astigmatism, it was shown that beginning at -0.50 D astigmatism, postoperative visual acuity of trifocal IOLs worsened significantly as astigmatism increased. It is therefore crucial that low degrees of preoperative astigmatism be addressed with toric versions of trifocal IOLs to improve visual outcomes and increase patient satisfaction [14]. In our practice, we use toric trifocal IOLs to correct preoperative corneal astigmatism − 0.50 D or more because we believe in maximizing visual potential [14]. This study aimed to evaluate whether this practice yields significant visual improvements. Methods This study was a retrospective cross sectional study of patients who underwent cataract surgery and were implanted with trifocal diffractive IOLs that were either toric or non-toric. The surgeries were done at a single center by a single surgeon from January 1, 2018 to December 31, 2023. This study was approved by the St. Cabrini Medical Center-Asian Eye Institute (SCMC-AEI) Review Committee. It was conducted following the Good Clinical Practice guidelines and tenets of the Declaration of Helsinki. Due to the retrospective nature of the study and the use of fully anonymized data, the requirement for informed consent was formally waived by the committee. Patients aged 40 to 80 years of age who had phacoemulsification in at least one eye were included. Other inclusion criteria were as follows: patients who had uneventful cataract surgery with implantation of either a hydrophilic or hydrophobic diffractive trifocal lens, had a preoperative corneal astigmatism ranging from − 0.50 D to -1.50 D measured via IOLMaster® 700 (Carl Zeiss AG, Germany), mean keratometry readings between 40.00 D and 48.00 D, mesopic pupil between 3.5 mm and 6.5 mm, had uncorrected and best corrected distance, intermediate, and near visual acuity measured preoperatively and postoperatively, and completed the data set required with at least 6 months of follow-up. The exclusion criteria were eyes that had other ocular pathology aside from a cataract, any preoperative, intraoperative, and postoperative complications related to the cataract surgery, eyes with any other ophthalmic procedure/surgery before the cataract surgery or had an immediate history of ocular surface disease, corneal pathology, uveitis, glaucoma, and retinal pathology that contributed to a decline in visual acuity as deemed by the main surgeon. Intraocular lens description FineVision Launched by Physiol in 2010, the FineVision (BVI Physiol, Liege, Belgium) family of intraocular lenses (IOLs) features a single-piece, biconvex, and aspheric acrylic design engineered to compensate for the positive spherical aberration of the cornea. These lenses are trifocal in nature, providing an add power of + 1.75 D for intermediate vision and + 3.50 D for near vision, and they all incorporate UV and blue-light filtering capacities. The family includes one toric model (POD FT) and three non-toric models (Micro F, POD F, and POD F GF), which are structurally unified by a double C-loop haptic design with 5° posterior vaulting. Despite sharing the same underlying platform, the models differ primarily in their material composition and structural markings: Both the toric POD FT (Fig. 1a) and non-toric POD F (Fig. 1b) are manufactured from a 26% hydrophilic acrylic copolymer material. To facilitate precise alignment during implantation, the toric POD FT model is uniquely distinguished from the non-toric POD F by orientation markings consisting of three vertical dots near the proximal end of both haptics. In contrast, the non-toric POD F GF is fabricated from a hydrophobic, glistening-free acrylic material. It features distinct linear markings on its haptics, differentiating it from the two hydrophilic models. While these material variations exist, previous studies comparing the visual outcomes of the POD F GF and POD F have demonstrated similar excellent results [17, 18]. This paper specifically utilizes the toric POD FT alongside the non-toric POD F and POD F GF models. a. FineVision (POD FT) b. FineVision (POD F) c. FineVision (POD F GF) Procedures and assessment Technical Review Committee and Ethics Committee approvals were secured. Patient charts from January 1, 2018, to December 31, 2023, were retrieved and patient data was obtained according to the inclusion and exclusion criteria of the study. The data was integrated to create correlations and analyses in line with the objectives of the paper. A total of 167 eyes were eligible of which 88, 46, and 33 eyes were implanted with a FineVision POD FT, FineVision POD F GF, and FineVision POD F IOL respectively. The patients had a complete preoperative evaluation with slit lamp examination and dilated fundus examination for optic nerve and retina evaluation, cataract screening diagnostics, and filled out the consent forms. Preoperative data included uncorrected and corrected distance, intermediate, and near visual acuity, manifest refraction, intraocular pressure measurement, and optical biometry using the IOLMaster® 700 (Carl Zeiss AG, Germany). IOL power was calculated online using the formulas on www.apacrs.org. The Barrett Toric Calculator v2.5 targeting emmetropia was used with 119.0 as a personalized A-constant when using the FineVision POD FT. The Barrett Universal II Formula v1.05 online calculator targeting emmetropia was used with 119.0 and 119.6 as personalized A-constants for FineVision POD F and FineVision POD F GF, respectively. Conventional cataract surgery with a manual capsulorrhexis was performed in 51 eyes for the toric group and 41 eyes for the non-toric group. Femtosecond laser-assisted cataract surgery using the Victus femtosecond laser (Bausch and Lomb Technolas, Munich, Germany) was performed in 37 eyes for the toric group and 38 eyes for the non-toric group. All surgeries were performed by a single surgeon. The location of the main corneal incision was standardized at 210° for right eyes and 30° for left eyes and was not routinely adjusted according to the patient’s corneal topography or steep corneal axis. Astigmatism management was primarily achieved through toric IOL selection and alignment guided by the Barrett Toric Calculator v2.5. The surgically induced astigmatism (SIA) value was pegged at 0.12. Postoperative evaluations included in this study were all done from 6 to 12 months of follow-up which included manifest refraction, uncorrected and corrected distance, intermediate (66 cm), and near (40 cm) visual acuity, and questionnaire response. Patients implanted with the trifocal non-toric IOL were then grouped according to the recommendation of the Barrett Toric Calculator v2.5 into those who were recommended to receive toric IOLs but were implanted non-toric lenses due to patient preference (Non-Toric IOL that should have been Toric or NTT group), and those who were recommended to receive non-toric lenses that were implanted non-toric lenses (Non-toric IOL, Non-Toric or NTNT group). The patients who were recommended to receive a toric IOL and were implanted with the trifocal toric IOL were labeled the True Toric (TT) group. All groups were then categorized according to the magnitude of corneal astigmatism based on IOL Master readings: -0.50 D to -0.75 D, -0.76 D to -1.00 D, and − 1.01 D to -1.50 D. All groups and categories were then divided according to the orientation of the astigmatism: with-the-rule, against-the-rule, and oblique astigmatism. Subgroup analyses were primarily focused on − 0.50 to − 1.00 D astigmatism; the − 1.01 to − 1.50 D group was included for descriptive completeness. Our standard of care is using these validated questionnaires to gain feedback from patients who received presbyopia-correcting IOLs (Catquest-9SF questionnaire [31], Modified TyPE questionnaire [32], Quality of Vision questionnaire [33], and Near Activity Visual Questionnaire [34]). Responses to these questionnaires were collected and collated. These questions pertained to the presence of glare, haloes, difficulty in dim light, and how good their near, intermediate, and distance vision was, and overall patient satisfaction. A potential limitation of this study is the uneven distribution of corneal astigmatism severity between the toric (TT) and non-toric (NTT/NTNT) groups, particularly the absence of eyes with ≥ 1.00 D corneal astigmatism in the NTT subgroup. This reflects real-world clinical decision-making, wherein toric intraocular lenses were preferentially selected for higher magnitudes of astigmatism based on preoperative biometry and established surgical planning guidelines. As such, complete overlap in astigmatism range between groups was not feasible, and comparisons at higher cylinder levels are inherently limited. To mitigate this, subgroup analyses were performed within overlapping astigmatism strata (0.50–1.00 D), allowing more balanced comparisons. Nevertheless, residual confounding due to treatment selection bias may still influence overall group comparisons, and findings should therefore be interpreted within the context of this real-world, non-randomized treatment allocation. Statistical analysis Data results were input into a password-protected Excel spreadsheet (Microsoft Corp., USA). At 95% confidence level and 80% power of the test, the minimum required number of eyes was at least 109. The R-programme and SPSS 18 were used for data analysis. Given the limited standalone clinical interpretability of refractive sphere in the presence of astigmatic correction, primary refractive outcome measures were focused on manifest refractive spherical equivalent (MRSE) and residual refractive cylinder. Refractive sphere was reported for completeness but was not used as a primary comparative endpoint. Frequency, percentage, mean, and standard deviation were used to describe the profile of the patients. The Analysis of Variance (One-way ANOVA) was used to compare visual and refractive outcomes between the three groups of patients: True Toric (TT), Non-Toric IOL that should have been Toric (NTT), and Non-Toric IOL, Non-Toric (NTNT) and the subgroupings and subcategories of magnitude and orientation of astigmatism. Bivariate comparisons were done using Tukey’s test. In special cases where there were only two groups of data available, an independent T-test was used. The Chi-square test was used to compare categorical variables such as the answers to the questionnaires. The null hypotheses were rejected at the 0.05-alpha level of significance or 95% confidence level. Results Among the study cohort, 88 eyes received toric IOLs (TT group), while 79 eyes were implanted with non-toric IOLs. These 79 non-toric eyes were further stratified based on postoperative analysis using the Barrett Toric Calculator into two subgroups: NTT (n = 65), representing eyes in which toric IOL implantation would have been indicated, and NTNT (n = 14), representing eyes appropriately managed with non-toric IOLs. Table 1 shows the demographics and mean preoperative data. Ranging from 47 to 83 years old, the mean age was 66.35 ± 8.74 years for the TT group, 68.98 ± 6.66 years for the NTT group, and 66.57 ± 7.30 years for the NTNT group. The TT group had a balanced gender ratio with slightly more females (60.23%), the NTT group had a higher proportion of females (66.15%), while the NTNT group was predominantly female (85.71%). The three groups showed similar proportions of patients undergoing Victus femtolaser-assisted cataract surgery with the NTT group having a higher proportion (50.70%) compared to the TT group (42.00%) and NTNT group (35.70%). (Table 1) Table 1Demographics and preoperative dataVariablesTrue Toric(TT) N = 88Non-Toric IOL, Toric (NTT)N = 65Non-Toric IOL, Non-Toric (NTNT) N = 14Age (years)66.35 ± 8.7468.98 ± 6.6666.57 ± 7.30Sex Female53 (60.23%)43 (66.15%)12 (85.71%) Male35 (39.77%)22 (33.85%)2 (14.29%)Operative ProcedureFLACS37 (42.05%)33 (50.77%)5 (35.71%)ConventionalPhacoemulsification51 (57.95%)32 (49.23%)9 (64.29%)Preop VA (logMAR) UDVA0.58 ± 0.520.38 ± 0.310.70 ± 0.61 UIVA0.5 ± 0.310.38 ± 0.130.48 ± 0.18 UNVA0.58 ± 0.30.60 ± 0.180.58 ± 0.24 CDVA0.11 ± 0.150.17 ± 0.160.10 ± 0.10 DCIVA0.28 ± 0.190.33 ± 0.120.33 ± 0.15 DCNVA0.51 ± 0.160.52 ± 0.150.50 ± 0.17Refractive Errors (D) Sphere0.01 ± 2.930.75 ± 1.85-0.21 ± 3.05 Cylinder-1.04 ± 0.62-0.98 ± 0.55-0.78 ± 0.32 MRSE-0.51 ± 2.990.24 ± 1.56-0.48 ± 3.06Corneal Cylinder (D)-1.01 ± 0.27-0.69 + 0.13-0.64 + 0.10FLACS femtosecond laser-assisted cataract surgery; VA visual acuity; logMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent Demographics and preoperative data Conventional Phacoemulsification FLACS femtosecond laser-assisted cataract surgery; VA visual acuity; logMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent The mean preoperative corneal cylinder via IOLMaster® 700 (Carl Zeiss AG, Germany), mean postoperative refractive cylinder, and P-values are as follows: -1.01 ± 0.27 vs. -0.4 ± 0.29 (P = < 0.01) for the TT group, -0.69 ± 0.13 vs. -0.68 ± 0.36 (P = 0.83) for the NTT group, and − 0.64 ± 0.10 vs. -0.41 ± 0.25 (P = < 0.01) for the NTNT group. Bivariate analysis of the preoperative and postoperative values showed effective post-surgical correction of corneal cylinder in the TT group. (Tables 2, 3 and 4) Table 2Preoperative and postoperative cylinder comparisonVariablesTrue Toric (TT)N = 88Non-Toric IOL, Toric (NTT)N = 65Non-Toric IOL, Non-Toric (NTNT)N = 14P-ValuePreop Corneal Cylinder (IOLMaster)-1.01 ± 0.27-0.69 ± 0.13-0.64 + 0.100.00**Postop Refractive Cylinder-0.40 ± 0.29-0.68 ± 0.36-0.41 + 0.250.00**P-Value0.00**0.830.00**** Statistically significant difference between groups at p ≤ 0.01 Preoperative and postoperative cylinder comparison ** Statistically significant difference between groups at p ≤ 0.01 Table 3Preoperative corneal cylinder vs. postoperative refractive cylinderVariablesTrue Toric (TT)Non-Toric IOL,Toric (NTT)P-Value-0.50 to -1.50 DN = 88N = 65Preop CornealCylinder-1.01 ± 0.27-0.69 ± 0.130.00*Postop RefractiveCylinder-0.4 ± 0.29-0.68 ± 0.360.00*-0.50 to -0.75 DN = 17N = 48Preop CornealCylinder-0.63 ± 0.08-0.63 ± 0.081.00Postop RefractiveCylinder-0.46 ± 0.36-0.67 ± 0.350.04*-0.76 to -1.00 DN = 27N = 17Preop CornealCylinder-0.89 ± 0.08-0.89 ± 0.091.00Postop RefractiveCylinder-0.44 ± 0.25-0.72 ± 0.390.001**-1.01 to -1.50 DN = 44N = 0Preop CornealCylinder-1.24 ± 0.15N/AN/APostop RefractiveCylinder-0.87 ± 0.52N/AN/AD diopters* Statistically significant difference between groups at p ≤ 0.05** Statistically significant difference between groups at p ≤ 0.01 Preoperative corneal cylinder vs. postoperative refractive cylinder Preop Corneal Cylinder Postop Refractive Cylinder Preop Corneal Cylinder Postop Refractive Cylinder Preop Corneal Cylinder Postop Refractive Cylinder Preop Corneal Cylinder Postop Refractive Cylinder D diopters * Statistically significant difference between groups at p ≤ 0.05 ** Statistically significant difference between groups at p ≤ 0.01 Table 4Preoperative and postoperative LogMAR VA and refractionVariablesTrue Toric(TT) aN = 88Non-Toric IOL, Toric (NTT) aN = 65Non-Toric IOL, Non-Toric (NTNT) bN = 14LogMAR UDVA Preop0.58 ± 0.540.38 ± 0.310.70 ± 0.60 Postop0.06 ± 0.090.07 ± 0.090.06 ± 0.06LogMAR UIVA Preop0.49 ± 0.320.38 ± 0.130.49 ± 0.18 Postop0.08 ± 0.120.08 ± 0.110.09 ± 0.09LogMAR UNVA Preop0.58 ± 0.30.60 ± 0.170.58 ± 0.24 Postop0.11 ± 0.130.11 ± 0.110.12 ± 0.12LogMAR CDVA Preop0.11 ± 0.150.17 ± 0.160.10 ± 0.10 Postop0.03 ± 0.070.04 ± 0.050.04 ± 0.06LogMAR DCIVA Preop0.28 ± 0.190.33 ± 0.120.33 ± 0.15 Postop0.06 ± 0.150.07 ± 0.090.1 ± 0.09LogMAR DCNVA Preop0.51 ± 0.160.52 ± 0.150.50 ± 0.17 Postop0.1 ± 0.120.11 ± 0.110.11 ± 0.12Refractive Sphere (D) Preop0.01 ± 2.930.75 ± 1.85-0.21 ± 3.05 Postop0.17 ± 0.360.38 ± 0.480.25 ± 0.26Refractive Cylinder (D) Preop-1.04 ± 0.62-0.98 ± 0.55-0.79 ± 0.32 Postop-0.4 ± 0.29-0.68 ± 0.36-0.41 ± 0.25MRSE (D) Preop-0.51 ± 2.990.24 ± 1.56-0.48 ± 3.06 Postop-0.03 ± 0.360.04 ± 0.390.11 ± 0.21LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalenta Postoperative values at 11 monthsb Postoperative values at 10 months Preoperative and postoperative LogMAR VA and refraction LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent a Postoperative values at 11 months b Postoperative values at 10 months In the entire cohort, the mean preoperative corneal cylinder was − 1.01 ± 0.27 D for the TT group and − 0.69 ± 0.13 D for the NTT group. Bivariate analysis of these results revealed a P-value of < 0.001, signifying that the preoperative population has a predominance of a higher magnitude of corneal astigmatism within the TT group. In the − 0.50 D to -0.75 D corneal astigmatism subgroup, the mean preoperative corneal cylinder was − 0.63 ± 0.08 D for the TT group and − 0.63 ± 0.08 D for the NTT group. Bivariate analysis of these results revealed a P-value of 1.00, signifying that the preoperative population did not differ in magnitude of astigmatism comparing the two groups. In the − 0.76 D to -1.00 D corneal astigmatism subgroup, the mean preoperative corneal cylinder was − 0.89 ± 0.08 D for the TT group and − 0.89 ± 0.09 D for the NTT group. (Table 3) In the entire cohort, the mean postoperative refractive cylinder was − 0.40 ± 0.29 D for the TT group and − 0.68 ± 0.36 D for the NTT group. Bivariate analysis of these results revealed a P-value of < 0.001 signifying a more effective refractive correction of cylinder when using toric IOLs compared to non-toric IOLs in this population. In the − 0.50 D to -0.75 D corneal astigmatism subgroup, the mean postoperative refractive cylinder was − 0.46 ± 0.36 D for the TT group and − 0.67 ± 0.35 D for the NTT group. Bivariate analysis of these results revealed a P-value of 0.04 signifying a more effective refractive correction of cylinder when using toric IOLs compared to non-toric IOLs in this population. In the − 0.76 D to -1.00 D corneal astigmatism subgroup, the mean postoperative refractive cylinder was − 0.44 ± 0.25 D for the TT group and − 0.72 ± 0.39 D for the NTT group. Bivariate analysis of these results revealed a P-value of 0.001 signifying a more effective refractive correction of cylinder when using toric IOLs compared to non-toric IOLs in this population. (Table 3) In the − 1.01 D to -1.50 D corneal astigmatism subgroup, the mean preoperative corneal cylinder was − 1.24 ± 0.15 D and the mean postoperative refractive cylinder was − 0.87 ± 0.52 D for the TT group. There were no eyes with corneal cylinder above − 1.0 D in the NTT group. (Table 3) Table 4 shows mean preoperative and postoperative visual and refractive outcomes among the 3 groups (TT, NTT, and NTNT). The mean postoperative follow up period was 11 months for the TT group, 11 months for the NTT group, and 10 months for the NTNT group. (Table 4) The mean postoperative logMAR UDVA was 0.06 ± 0.09 for the TT group and 0.07 ± 0.09 for the NTT group. The mean postoperative logMAR uncorrected intermediate visual acuity (UIVA) was 0.08 ± 0.12 for the TT group and 0.08 ± 0.11 for the NTT group. The mean postoperative logMAR uncorrected near visual acuity (UNVA) was 0.11 ± 0.13 for the TT group and 0.11 ± 0.11 for the NTT group. Bivariate analysis of these results revealed that overall uncorrected distance, intermediate, and near vision of trifocal non-toric IOLs are non-inferior to trifocal toric IOLs. (Table 5). The mean postoperative refractive cylinder was − 0.4 ± 0.29 D for the TT group and − 0.68 ± 0.36 D for the NTT group. Bivariate analysis of these results revealed a P-value of < 0.001 signifying a more effective refractive correction of cylinder when using toric IOLs compared to non-toric IOLs in this population. (Table 5). A postoperative refractive astigmatism of ≤ -0.50 D was 84% in the TT group and 55% in the NTT group. (Fig. 2) Table 5Postoperative outcomes of TT (all eyes) vs. NTT (all eyes)VariablesTrue Toric (TT)N = 88Non-Toric IOL, Toric (NTT)N = 65P-ValueLogMAR UDVA0.06 ± 0.090.07 ± 0.090.50LogMAR UIVA0.08 ± 0.120.08 ± 0.111.00LogMAR UNVA0.11 ± 0.130.11 ± 0.111.00LogMAR CDVA0.03 ± 0.070.04 ± 0.050.33LogMAR DCIVA0.06 ± 0.150.07 ± 0.090.63LogMAR DCNVA0.1 ± 0.120.11 ± 0.110.60Refractive Sphere (D)0.17 ± 0.360.38 ± 0.480.002**Refractive Cylinder (D)-0.4 ± 0.29-0.68 ± 0.36< 0.001**MRSE (D)-0.03 ± 0.360.04 ± 0.390.33LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent** Statistically significant difference between groups at p ≤ 0.01 Postoperative outcomes of TT (all eyes) vs. NTT (all eyes) LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent ** Statistically significant difference between groups at p ≤ 0.01 Cumulative Postoperative Refractive Cylinder in the TT, NTT, and NTNT Groups In the TT group, the graph showed a reduction in corneal cylinder seen as the levels of astigmatism shifting to the left after implantation of a low toric trifocal IOL. In the NTT group, the corneal cylinder remained mostly uncorrected after cataract extraction and implantation of a non-toric trifocal IOL. (Tables 4 and 5). In the − 0.76 D to -1.00 D corneal astigmatism subgroup, the mean postoperative refractive cylinder was − 0.44 ± 0.25 for the TT group and − 0.72 ± 0.39 for the NTT group. Bivariate analysis of the mean postoperative residual cylinder of the TT and NTT groups revealed a P-value of 0.006, signifying more effective refractive correction when using trifocal toric IOLs compared to trifocal non-toric IOLs. (Table 6) Table 6Postoperative findings (VA in logMAR) comparing the TT and NTT groups in the − 0.76 D to -1.00 D Corneal Cylinder subgroupVariablesTrue Toric (TT)N = 88Non-Toric IOL, Toric (NTT)N = 65P-ValueLogMAR UDVA0.05 ± 0.080.07 ± 0.070.40LogMAR UIVA0.10 ± 0.120.08 ± 0.120.59LogMAR UNVA0.11 ± 0.120.10 ± 0.100.78LogMAR CDVA0.03 ± 0.070.02 ± 0.040.60LogMAR DCIVA0.04 ± 0.190.05 ± 0.070.84LogMAR DCNVA0.10 ± 0.110.09 ± 0.090.76Refractive Sphere (D)0.19 ± 0.350.39 ± 0.530.14Refractive Cylinder (D)-0.44 ± 0.25-0.72 ± 0.390.006**MRSE (D)-0.04 ± 0.33-0.04 ± 0.390.47LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent** Statistically significant difference between groups at p ≤ 0.01 Postoperative findings (VA in logMAR) comparing the TT and NTT groups in the − 0.76 D to -1.00 D Corneal Cylinder subgroup LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent ** Statistically significant difference between groups at p ≤ 0.01 In the subgroup of the − 0.76 D to -1.00 D corneal astigmatism, bivariate analysis of the mean postoperative logMAR uncorrected distance, intermediate, and near visual acuity (UDVA) of the TT and NTT groups revealed no statistical difference. (Table 6). In the subgroup of the − 0.76 D to -1.00 D corneal astigmatism and subcategory of the against-the-rule astigmatism, the mean postoperative logMAR UDVA was 0.04 ± 0.05 for the TT group and 0.15 ± 0.04 for the NTT group. Bivariate analysis of the mean postoperative logMAR UDVA of the TT and NTT groups revealed a P-value of 0.008 signifying that the trifocal toric IOLs provided better UDVA in this subgroup when compared to non-toric IOLs. (Table 7) The mean postoperative logMAR uncorrected intermediate and near visual acuity was not statistically different. The refractive sphere and spherical equivalent was likewise significantly different. Table 7Postoperative findings (VA in logMAR) comparing the TT and NTT groups in the − 0.76 D to -1.00 D Corneal Cylinder subgroup and Against-The-Rule Astigmatism subcategoryVariablesTrue Toric (TT)N = 8Non-Toric IOL, Toric (NTT)N = 3P-ValueLogMAR UDVA0.04 ± 0.050.15 ± 0.040.008**LogMAR UIVA0.09 ± 0.100.13 ± 0.230.68LogMAR UNVA0.06 ± 0.070.10 ± 0.170.57LogMAR CDVA0.01 ± 0.040.03 ± 0.070.56LogMAR DCIVA-0.05 ± 0.270.03 ± 0.060.63LogMAR DCNVA0.06 ± 0.070.10 ± 0.170.57Refractive Sphere (D)0.19 ± 0.261.00 ± 0.750.02*Refractive Cylinder (D)-0.59 ± 0.23-1.00 ± 0.500.08MRSE (D)-0.11 ± 0.290.50 ± 0.500.03*LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent* Statistically significant difference between groups at p ≤ 0.05** Statistically significant difference between groups at p ≤ 0.01 Postoperative findings (VA in logMAR) comparing the TT and NTT groups in the − 0.76 D to -1.00 D Corneal Cylinder subgroup and Against-The-Rule Astigmatism subcategory LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; UIVA uncorrected intermediate visual acuity; UNVA uncorrected near visual acuity; CDVA corrected distance visual acuity; DCIVA distance-corrected intermediate visual acuity; DCNVA distance-corrected near visual acuity; D diopters; MRSE manifest refraction spherical equivalent * Statistically significant difference between groups at p ≤ 0.05 ** Statistically significant difference between groups at p ≤ 0.01 Across the cohort and its subgroups, postoperative UDVA outcomes were generally comparable between TT and NTT, demonstrating non-inferiority of NTT in most cases. However, TT consistently achieved significantly lower residual refractive cylinder, particularly in the overall group, as well as in the oblique astigmatism and higher corneal astigmatism subgroups, highlighting their superior efficacy in correcting astigmatism. Notably, in patients with − 0.76 D to -1.00 D against-the-rule astigmatism, TT provided better UDVA, suggesting an additional visual advantage in this subset. (Table 8). A postoperative UDVA of 20/20 or better was achieved in 58% of eyes in the TT group, 51% of eyes in the NTT group, and 50% of eyes in the NTNT group. All eyes had UDVA of 20/40 or better. A postoperative corrected distance visual acuity (CDVA) of 20/20 or better was achieved in 73% of eyes in the TT group, 69% of eyes in the NTT group, and 64% of eyes in the NTNT group. All eyes had a CDVA of 20/40 or better. (Figures 3, 4 and 5). Table 8Postop refractive cylinder vs. uncorrected distance visual acuityVariablesTrue Toric (TT)Non-Toric Toric (NTT)P-Value-0.50 to -1.50 DN = 88N = 65 LogMAR UDVA0.06 ± 0.090.07 ± 0.090.50 Refractive Cylinder (D)-0.4 ± 0.29-0.68 ± 0.360.001** With-the-RuleN = 42N = 13 LogMAR UDVA0.08 ± 0.100.04 ± 0.070.19 Refractive Cylinder (D)-0.35 ± 0.27-0.56 ± 0.490.052 Against-the-RuleN = 12N = 16 LogMAR UDVA0.03 ± 0.050.08 ± 0.090.10 Refractive Cylinder (D)-0.48 ± 0.31-0.78 ± 0.350.026* ObliqueN = 34N = 36 LogMAR UDVA0.05 ± 0.090.09 ± 0.090.06 Refractive Cylinder (D)-0.44 ± 0.30-0.69 ± 0.310.001**-0.50 to -0.75 DN = 17N = 48 LogMAR UDVA0.08 ± 0.110.07 ± 0.090.73 Refractive Cylinder (D)-0.46 ± 0.36-0.67 ± 0.350.03* With-the-RuleN = 3N = 7 LogMAR UDVA0.09 ± 0.090.05 ± 0.090.53 Refractive Cylinder (D)-0.50 ± 0.25-0.64 ± 0.660.73 Against-the-RuleN = 4N = 13 LogMAR UDVA0.03 ± 0.050.06 ± 0.090.54 Refractive Cylinder (D)-0.25 ± 0.35-0.73 ± 0.310.01* ObliqueN = 10N = 28 LogMAR UDVA0.08 ± 0.120.09 ± 0.090.78 Refractive Cylinder (D)-0.53 ± 0.40-0.65 ± 0.280.31-0.76 to -1.00 DN = 27N = 17 LogMAR UDVA0.05 ± 0.080.07 ± 0.070.40 Refractive Cylinder (D)-0.44 ± 0.25-0.72 ± 0.390.006** With-the-RuleN = 9N = 6 LogMAR UDVA0.06 ± 0.080.00 ± 0.000.09 Refractive Cylinder (D)-0.43 ± 0.31-0.42 ± 0.140.94 Against-the-RuleN = 8N = 3 LogMAR UDVA0.04 ± 0.050.15 ± 0.040.008** Refractive Cylinder (D)-0.59 ± 0.23-1.00 ± 0.500.08* ObliqueN = 10N = 8 LogMAR UDVA0.02 ± 0.040.07 ± 0.070.07 Refractive Cylinder (D)-0.35 ± 0.21-0.81 ± 0.390.006**LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; D diopters* Statistically significant difference between groups at p ≤ 0.05** Statistically significant difference between groups at p ≤ 0.01 Postop refractive cylinder vs. uncorrected distance visual acuity LogMAR logarithm of the mimimum angle of resolution; UDVA uncorrected distance visual acuity; D diopters * Statistically significant difference between groups at p ≤ 0.05 ** Statistically significant difference between groups at p ≤ 0.01 Cumulative postoperative UDVA vs. CDVA, TT Cumulative postoperative UDVA vs. CDVA, NTT Cumulative postoperative UDVA vs. CDVA, NTNT The 3 groups were compared as to patient-reported outcomes on how bothersome glare or haloes are, difficulty in dim light, quality of intermediate vision, and satisfaction with vision. There was no statistical significance on analysis of the 3 groups regarding patient-reported outcomes (Table 9). Table 9Patient-reported outcomesQuestions and ResponsesTrue ToricN = 65Non-Toric IOL, ToricN = 34Non-Toric, Non-ToricN = 5P-valueHow bothersome is the glare?0.31 Not at all4366%1956%360% A little812%515%00% Quite1422%1029%240% Very bothersome00%00%00%How bothersome are the haloes?0.99 Not at all4468%2368%480% A little1320%926%120% Quite711%26%00% Very bothersome12%00%00%How much difficulty do you have in dim light?0.59 No difficulty5280%1647%360% A little1117%926%240% Moderate23%412%00% Extreme difficulty00%00%00%How good is your near vision?0.59 No difficulty5382%2882%5100% A little812%515%00% Moderate46%13%00% Extreme difficulty00%00%00%How good is your intermediate vision?0.99 No difficulty6092%3191%5100% A little46%39%00% Moderate12%00%00% Extreme difficulty00%00%00%How satisfied are you with your vision?0.05* Very satisfied2234%2368%360% Satisfied3555%1029%240% Neither58%13%00% Dissatisfied23%00%00% Very dissatisfied00%00%00%* Statistically significant difference between groups at p ≤ 0.05 Patient-reported outcomes * Statistically significant difference between groups at p ≤ 0.05 The Six Standard Graph analysis was performed for the 88 eyes in the TT cohort. Efficacy analysis demonstrated excellent uncorrected postoperative visual acuity, with the majority of eyes achieving UDVA better than their preoperative corrected distance visual acuity. Safety analysis showed preservation or improvement of CDVA in most eyes with predictability analysis demonstrated a high proportion of eyes within ± 0.50 D and ± 1.00 D of the intended spherical equivalent target. Postoperative refractive astigmatism analysis confirmed effective cylinder reduction following implantation of the toric trifocal IOL, consistent with the observed decrease in mean refractive cylinder from − 1.01 ± 0.27 D preoperatively to − 0.40 ± 0.29 D postoperatively. Attempted-versus-achieved correction demonstrated a strong correlation between intended and achieved refractive outcomes. Stability analysis showed stable refractive results throughout the postoperative follow-up period (Fig. 6). Six standard graph analysis in true toric group Discussion The main purpose of this study was to determine whether the implantation of a trifocal toric IOL in patients with low levels of corneal astigmatism would yield significantly better refractive and visual outcomes. Novel IOL technology has been geared towards the correction of near, intermediate, and far vision and can be achieved with the trifocal variants of the IOLs. The presence of concomitant astigmatism can cause significant blurring of vision despite correction with a trifocal lens. Toric IOLs have been developed to correct astigmatism but are more expensive and require more tedious steps before and during surgery. It has been documented in multiple studies that astigmatism affects trifocal IOLs more than monofocal IOLs [19–22]. Ang reported that multifocal IOLs, particularly trifocal designs, are considerably less tolerant of residual corneal astigmatism than monofocal IOLs. While monofocal lenses may maintain functional vision with up to -1.50 D of astigmatism, multifocal IOLs demonstrate a notable reduction in visual acuity with as little as -0.50 D to -0.75 D. [22] Hence, correction of astigmatism is imperative for overall excellent quality of vision given that astigmatism of -0.50 D or more is present in up to 86% of the population. [23, 24] There are recommendations to correct astigmatism starting at -1.00 D cylinder [25] and a study by Hayashi et al. recommends correction starting at -0.75 D cylinder. [19] Visser states that implanting a toric IOL is currently the easiest and most effective way of correcting astigmatism. [26] In a multivariate analysis by Schallhorn in 2021, they advised to include corneal astigmatism of -0.50 D or greater in surgical planning. [13] Our study compared postoperative outcomes of eyes with preoperative corneal astigmatism ranging from − 0.50 D to -1.50 D measured using the IOLMaster® 700 (Carl Zeiss AG, Germany). We divided the eyes to -0.50 D to -0.75 D, -0.76 D to -1.00 D, and − 1.01 D to -1.50 D to determine which level of astigmatism would benefit from implantation and serve as a cut-off in recommending the use of toric trifocal IOLs. We further subdivided the eyes into axis of with-the-rule, against-the-rule and oblique astigmatism to determine if the axis would influence outcomes. A comparison of the postoperative refractive cylinder of the TT group (0.4 ± 0.29) and the NTT group (0.68 ± 0.36) revealed a P-value of < 0.01. This indicates that the TT group exhibits a statistically significant decrease in postoperative refractive cylinder when compared to the NTT group. Leon demonstrated a similar postoperative refractive cylinder in patients with low levels of corneal astigmatism implanted with toric IOLs at − 0.40 ± 0.20 D. [27] Ernest et al. found that in a similar population, those implanted with toric IOLs had significantly lower postoperative refractive cylinders compared to their preoperative findings (-0.31 D vs. -1.06 D; P ≤ 0.001). [28] Gundersen in 2020 described that the mean postoperative manifest refractive cylinder was significantly lower in the low toric group (~-0.25D; P ≤ 0.01). [29] Mingo-Botin reported that residual corneal astigmatism after implantation of a toric IOL was at -0.61 D ± 0.41. [30] The results of our study are consistent with those of previous literature. Preoperative corneal astigmatism in the TT group was at -1.01 ± 0.27, while postoperative refractive cylinder was at -0.4 ± 0.29 with a P-value of < 0.001. This indicates a significant improvement in postoperative cylinder. In comparison, the preoperative corneal astigmatism in the NTT group was − 0.69 ± 0.13 with a postoperative refractive cylinder of -0.68 ± 0.36, P-value = 0.83. This indicates no statistically significant improvement or difference in cylinder postoperatively. The postoperative UDVA, UIVA, and UNVA of the TT and NTT groups were compared. The mean postoperative UDVA was 0.06 ± 0.09 for the TT group and 0.07 ± 0.09 for the NTT group (P = 0.50). The mean postoperative UIVA was 0.08 ± 0.12 for the TT group and 0.08 ± 0.11 for the NTT group (P = 1.00). The mean postoperative UNVA was 0.11 ± 0.13 for the TT group and 0.11 ± 0.11 for the NTT group (P = 1.00). While the use of trifocal toric IOLs significantly decreased the magnitude of refractive cylinder in the − 0.50 D to -1.00 D corneal cylinder groups, this did not translate to a significant difference in uncorrected visual acuities. The possible reasons are the overall low levels of manifest refraction spherical equivalent (MRSE), the low number of subjects to show statistical difference, or the forgiving optics of the trifocal IOL. Therefore, the trifocal non-toric IOL proved to be non-inferior across all three focal points. Data was subcategorized according to the orientation of the astigmatism. In patients with oblique astigmatism, postoperative astigmatism was noted at -0.44 ± 0.30 for the TT group (n = 34) and − 0.69 ± 0.23 for the NTT group (n = 36) with a P-value of 0.001. This indicates a statistically significant difference in residual postoperative astigmatism with lower residual astigmatism seen in patients given a toric IOL. Similarly, the postoperative astigmatism seen in the against-the-rule group were − 0.50 ± 0.30 for the TT group (n = 12) and − 0.78 ± 0.35 for the NTT group (n = 16), with a P-value of 0.02 indicating a statistically significant difference. However, the with-the-rule astigmatism subgroup showed astigmatisms of -0.35 ± 0.27 for the TT group (n = 42) and − 0.56 ± 0.49 for the NTT group (n = 13), with a P-value of 0.052, showing no statistically significant difference between the two groups. These findings align with those of Gundersen in 2020, when he stated that correction of the postoperative cylinder is more pronounced in the against-the-rule orientation of astigmatism vs. with-the-rule astigmatism. [29] In contrast, however, a study by Ernest et al. in 2011 noted that the axis of the preoperative corneal astigmatism did not yield statistically significant results. [28]. With the data subcategorized according to the magnitude of preoperative corneal astigmatism, the analysis showed lower postoperative refractive astigmatism in the TT group compared to the NTT group. The TT group showed a significantly better postoperative refractive cylinder of -0.46 ± 0.37 (n = 17) versus − 0.67 ± 0.35 (n = 48) for the NTT group within the − 0.50 D to -0.75 D cylinder subgroup (P = 0.03). A similarly significant result was seen in the − 0.76 D to -1.00 D cylinder subgroup with − 0.44 ± 0.25 (n = 27) for the TT group and − 0.72 ± 0.39 (n = 17) for the NTT group (P = 0.006). Interestingly, we found that despite the absence of statistical significance in the − 0.76 D to -1.00 D cylinder subgroup within the against-the-rule subcategory, comparing postoperative refractive cylinder of -0.59 ± 0.23 (n = 8) in the TT group and − 1.00 ± 0.50 (n = 3) in the NTT group (P = 0.08), there was a statistically significant improvement in logMAR UDVA. The logMAR UDVA of the TT and NTT groups were 0.04 ± 0.05 and 0.15 ± 0.04, respectively with a P = 0.008 favoring the TT group. The postoperative refractive sphere of the TT group was 0.19 ± 0.26 and of the NTT group 1.00 ± 0.75 was found to have a statical significant difference with P = 0.02. Paired along with the limited number of respondents in both subgroups (TT = 8, NTT = 3), these factors may play a role in the actual significance of the difference in UDVA in this particular subgroup. Patient-reported outcomes showed that the majority of TT patients (n = 65/88) expressed positive satisfaction, with 90% reporting being either “very satisfied” or “satisfied” with their vision, demonstrating consistent satisfaction across the group. While a higher proportion of NTT patients (n = 34/65) reported being “very satisfied,” TT patients had a markedly higher combined satisfaction rate compared to NTT patients (85%), underscoring the reliability and overall favorable visual experience with trifocal toric (TT) IOLs. The limitations of this study include a relatively small population. Despite reaching the 95% confidence interval of 109 patients in total, the eyes were grouped, subgrouped, and subcategorized into the different data stratifications to gain meaningful insights, but the numbers were lower and unequal per subcategory, which may have impacted the statistical analysis. The study population was restricted to eyes with corneal astigmatism ≥ 0.50 D, whereas in clinical practice toric IOLs may also be considered in selected cases with lower astigmatism, particularly against-the-rule astigmatism. This may limit the generalizability of the findings to broader real-world decision-making. A larger study cohort may influence or further strengthen the findings in the present study. The study is retrospective in nature, which makes it susceptible to inherent biases, such as selection bias. Performing a prospective study and randomizing the eyes with a corneal cylinder of -0.50 D to -1.00 D into toric or non-toric may show a better comparison. The visual outcomes and patient satisfaction may be applicable to this particular brand of trifocal IOL but may not show the same outcomes with other brands of trifocal lenses. Furthermore, post-operative astigmatism orientation and the potential occurrence of flipped astigmatism were not analyzed. Because overcorrection or axis misalignment can significantly degrade visual acuity and patient satisfaction—particularly with trifocal optics—the lack of this data limits our ability to fully assess the refractive precision of the toric versus non-toric models. There is still no agreement as to how low the threshold is to correct preoperative corneal astigmatism. We showed that beginning the correction at -0.50 D of preoperative corneal cylinder significantly results in lower postoperative refractive astigmatism compared to merely using a non-toric trifocal IOL. The low numbers of eyes in the subgroups may not have resulted in statistical significance but the trend of the benefit is seen. There is a statistically significant difference in distance visual acuity outcomes if the preoperative corneal astigmatism is greater than − 0.75 D cylinder in the against-the-rule orientation, favoring trifocal toric IOLs. Quality of vision is similar regardless of implantation of toric or non-toric models in preoperative corneal astigmatism of -0.5 D to -1.00D cylinder group suggesting good tolerance for astigmatism in this type of trifocal IOL. In conclusion, the use of the low toric models of trifocal IOLs resulted in a significant reduction in preoperative corneal astigmatism, leading to good visual outcomes. Correcting preoperative corneal astigmatism of at least − 0.75 D with against-the-rule astigmatism is particularly effective. Our study results show that when considering trifocal IOLs, patients will benefit from using low toric IOLs to correct preoperative corneal astigmatism of -0.50 D to -1.50D.